4.7 Review

Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection

Muthukumar Gunasekaran et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)

Article Immunology

Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction

Maddalena Peghin et al.

CLINICAL INFECTIOUS DISEASES (2019)

Article Immunology

Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction

Cynthia E. Fisher et al.

CLINICAL INFECTIOUS DISEASES (2016)

Article Cardiac & Cardiovascular Systems

ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus. infection in lung transplant recipients

Jens Gottlieb et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)

Article Infectious Diseases

Human metapneumovirus in lung transplant recipients: characteristics and outcomes

Fabian Niggli et al.

INFECTIOUS DISEASES (2016)

Article Cardiac & Cardiovascular Systems

Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency

Fay S. Burrows et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)

Article Immunology

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

D. R. Drozd et al.

TRANSPLANT INFECTIOUS DISEASE (2013)

Article Surgery

CXCR3 Chemokine Ligands During Respiratory Viral Infections Predict Lung Allograft Dysfunction

S. S. Weigt et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2012)

Article Cardiac & Cardiovascular Systems

Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation

Lily Li et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)

Article Immunology

Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients

B. B. Guzman-Suarez et al.

TRANSPLANT INFECTIOUS DISEASE (2012)

Article Critical Care Medicine

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

Martin R. Zamora et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Review Immunology

The human metapneumovirus: a case series and review of the literature

S. Shahda et al.

TRANSPLANT INFECTIOUS DISEASE (2011)

Article Cardiac & Cardiovascular Systems

Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy

Ilker Uckay et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)

Article Cardiac & Cardiovascular Systems

Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection

Andres Pelaez et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)

Article Critical Care Medicine

Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus

Peter Hopkins et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Respiratory System

A single-season prospective study of respiratory viral infections in lung transplant recipients

A. P. Milstone et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Article Cardiac & Cardiovascular Systems

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

AR Glanville et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)

Article Critical Care Medicine

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death

AP Khalifah et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)

Article Immunology

The epidemiology of parainfluenza virus infection in lung transplant recipients

RA Vilchez et al.

CLINICAL INFECTIOUS DISEASES (2001)